Enhancing the levels of pregnenolone, DHEA, and their sulfate forms, as well as modulating enzymes like CYP11B1 and AKR1C3, could help mitigate inflammation and neurodegeneration associated with MS. Here, AKR1C3 is linked to myeloid sarcoma.